Los Angeles Capital Management
UPB

Los Angeles Capital Management’s Upstream Bio Inc UPB Stock Holding History

Los Angeles Capital Management’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
+22,385
New +$188K ﹤0.01% 1236

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Los Angeles Capital Management's UPB Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in Upstream Bio Inc (UPB) in Q2 2026: 22,385 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #1236 among its holdings.

149 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Los Angeles Capital Management held 22,385 shares of Upstream Bio Inc worth $155K as of Q2 2026.
  • Upstream Bio Inc was a new Los Angeles Capital Management position in Q2 2026.
  • Upstream Bio Inc made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1236 holding.
  • 149 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.